HeartBeam's FDA-Cleared Cable-Free ECG Tech to Debut at JP Morgan Healthcare Conference
January 5, 2026 — HeartBeam announces FDA-cleared cable-free 12-lead ECG technology for arrhythmia assessment, with CEO presenting at JP Morgan 2026 Healthcare Conference ahead of Q1 commercial launch.